Get the Stockscreener App
2.86
4.76%
0.13
After Hours:
2.98
0.12
+4.20%
Sunshine Biopharma Inc Stock (SBFM) Forecast
The Sunshine Biopharma Inc (SBFM) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.1947, representing a -93.19% decrease from the current price of $2.86. The highest analyst price target is $0.3628, and the lowest is $0.0266.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month SBFM Price Target
Average 0.3847
(-86.55% Downside)
Is Sunshine Biopharma Inc (SBFM) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 55.51 | Neutral |
| STOCH(9,6) | 45.55 | Neutral |
| STOCHRSI(14) | 83.18 | Sell |
| MACD(12,26) | -0.0629 | Buy |
| ADX(14) | 30.38 | Buy |
| William %R | -37.64 | Neutral |
| CCI(14) | 74.53 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.4645
Buy
|
2.6084
Buy
|
| MA20 |
2.5848
Buy
|
2.6246
Buy
|
| MA50 |
2.8484
Buy
|
3.3099
Sell
|
| MA100 |
3.4437
Sell
|
17.70
Sell
|
| MA200 |
34.36
Sell
|
121.52
Sell
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, SBFM could be considered a Potential Buy, with 17 technical analysis indicators signaling 7 Buy signals, 6 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on SBFM, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 55.51 indicates that SBFM is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 45.55 indicates that SBFM is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 83.18 indicates that SBFM is oversold. This suggests that SBFM price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 30.38 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 74.53 indicates that SBFM is still overbought but not to an extreme extent.
Long-term SBFM price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Sunshine Biopharma Inc financial reports and earnings history, Sunshine Biopharma Inc (SBFM) stock could reach $1.3015 by 2030, $4.3388 by 2040 and $7.5861 by 2050. See the projected annual prices until 2050 of the Sunshine Biopharma Inc stock below:
- Sunshine Biopharma Inc (SBFM) is expected to reach an average price of $2.7389 in 2035, with a high prediction of $2.6989 and a low estimate of $2.6852. This indicates an $-4.23% rise from the last recorded price of $2.86.
- Sunshine Biopharma Inc (SBFM) stock is projected to chart a bullish course in 2040, with an average price target of $4.1993, representing an $46.83% surge from its current level. The forecast ranges from a conservative $4.2393 to a sky-high $4.3388.
- Our analysts predict Sunshine Biopharma Inc (SBFM) to jump 111.29% by 2045, soaring from $6.0424 to an average price of $6.0428, potentially reaching $5.9922. While $6.0424 is the low estimate, the potential upside is significant.
- Sunshine Biopharma Inc (SBFM) stock is expected to climb by 2050, reaching an average of $7.6261, a $166.65% jump from its current level. However, a wide range of estimates exists, with high and low targets of $7.5861 and $7.6588, respectively, highlighting the market's uncertainty.
Sunshine Biopharma Inc Stock (SBFM) Year by Year Forecast
Sunshine Biopharma Inc Stock (SBFM) Price Forecast for 2025
Sunshine Biopharma Inc Stock (SBFM) is expected to reach an average price of $0.3847 in 2025, with a high prediction of $0.7687 and a low estimate of $0.000594. This indicates an -86.55% fall from the last recorded price of $2.86.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.0611 | $0.0266 | $0.3628 | -97.86% |
| February, 2025 | $0.0641 | $0.000594 | $0.7294 | -97.76% |
| March, 2025 | $0.0737 | $0.0179 | $0.246 | -97.42% |
| April, 2025 | $0.0608 | $0.0108 | $0.0885 | -97.87% |
| May, 2025 | $0.342 | $0.00689 | $0.3991 | -88.04% |
| June, 2025 | $0.2589 | $0.2059 | $0.619 | -90.95% |
| July, 2025 | $0.1772 | $0.1149 | $0.299 | -93.80% |
| August, 2025 | $0.0355 | $0.0345 | $0.2155 | -98.76% |
| September, 2025 | $0.0998 | $0.0088 | $0.7687 | -96.51% |
| October, 2025 | $0.0546 | $0.0278 | $0.092 | -98.09% |
| November, 2025 | $0.0931 | $0.0914 | $0.0889 | -96.74% |
| December, 2025 | $0.0999 | $0.1214 | $0.0948 | -96.51% |
Sunshine Biopharma Inc Stock (SBFM) Price Forecast for 2026
The predicted value for Sunshine Biopharma Inc (SBFM) in 2026 is set at an average of $2.1219. Estimates vary from a peak of $4.1243 to a trough of $0.1196, indicating an -25.81% surge from the present price of $2.86.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.1427 | $0.1196 | $0.1116 | -95.01% |
| February, 2026 | $0.2209 | $0.1933 | $0.1683 | -92.28% |
| March, 2026 | $0.244 | $0.2481 | $0.2153 | -91.47% |
| April, 2026 | $0.2636 | $0.2518 | $0.2286 | -90.78% |
| May, 2026 | $0.2363 | $0.2496 | $0.2282 | -91.74% |
| June, 2026 | $0.2381 | $0.2471 | $0.2467 | -91.68% |
| July, 2026 | $0.2435 | $0.2587 | $0.2321 | -91.49% |
| August, 2026 | $0.4168 | $0.2722 | $0.414 | -85.43% |
| September, 2026 | $0.3952 | $0.4012 | $0.4069 | -86.18% |
| October, 2026 | $0.5076 | $0.3076 | $4.1243 | -82.25% |
| November, 2026 | $0.133 | $0.1296 | $0.5909 | -95.35% |
| December, 2026 | $0.7502 | $0.1563 | $3.2802 | -73.77% |
Sunshine Biopharma Inc Stock (SBFM) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Sunshine Biopharma Inc (SBFM) is $4.0983, with a high forecast of $8.1834 and a low forecast of $0.0132. This indicates an +43.30% increase from the last price of $2.86.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.6567 | $0.5434 | $8.1834 | -42.07% |
| February, 2027 | $0.0832 | $0.0132 | $3.1333 | -97.09% |
| March, 2027 | $0.3837 | $0.3936 | $0.5575 | -86.58% |
| April, 2027 | $0.4072 | $0.427 | $0.4138 | -85.76% |
| May, 2027 | $0.2907 | $0.5206 | $0.404 | -89.84% |
| June, 2027 | $0.4476 | $0.3541 | $0.4076 | -84.35% |
| July, 2027 | $0.7286 | $0.5109 | $0.6511 | -74.53% |
| August, 2027 | $0.5996 | $0.6346 | $0.6386 | -79.04% |
| September, 2027 | $0.6414 | $0.6279 | $0.625 | -77.57% |
| October, 2027 | $0.7448 | $0.6792 | $0.6599 | -73.96% |
| November, 2027 | $0.5657 | $0.6873 | $0.6921 | -80.22% |
| December, 2027 | $0.3554 | $0.2619 | $0.2952 | -87.57% |
Sunshine Biopharma Inc Stock (SBFM) Price Forecast for 2028
In 2028, Sunshine Biopharma Inc (SBFM) is projected to reach an average price of $0.5989, with a high projection of $0.7623 and a low estimate of $0.4354. This indicates an -79.06% fall from the last price of $2.86.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.4093 | $0.4354 | $0.3854 | -85.69% |
| February, 2028 | $0.5715 | $0.4922 | $0.5023 | -80.02% |
| March, 2028 | $0.7413 | $0.6324 | $0.6239 | -74.08% |
| April, 2028 | $0.6327 | $0.6627 | $0.6327 | -77.88% |
| May, 2028 | $0.715 | $0.6458 | $0.6936 | -75.00% |
| June, 2028 | $0.6957 | $0.7258 | $0.6896 | -75.67% |
| July, 2028 | $0.674 | $0.7011 | $0.6531 | -76.43% |
| August, 2028 | $0.7266 | $0.7099 | $0.7134 | -74.59% |
| September, 2028 | $0.777 | $0.7968 | $0.7551 | -72.83% |
| October, 2028 | $0.7803 | $0.7933 | $0.7623 | -72.72% |
| November, 2028 | $0.7472 | $0.7683 | $0.7571 | -73.87% |
| December, 2028 | $0.7392 | $0.7568 | $0.7554 | -74.15% |
Sunshine Biopharma Inc Stock (SBFM) Price Forecast for 2029
The 2029 price forecast for Sunshine Biopharma Inc Stock (SBFM) is $3.6809 on average, with a high prediction of $7.3401 and a low estimate of $0.0216. This represents an +28.70% increase from the previous price of $2.86.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.7216 | $0.7475 | $0.7242 | -74.77% |
| February, 2029 | $0.8986 | $0.7544 | $0.8876 | -68.58% |
| March, 2029 | $0.8646 | $0.8782 | $0.8863 | -69.77% |
| April, 2029 | $0.818 | $0.8281 | $0.8536 | -71.40% |
| May, 2029 | $0.8794 | $0.0216 | $3.6785 | -69.25% |
| June, 2029 | $0.6804 | $0.1204 | $2.4203 | -76.21% |
| July, 2029 | $3.5001 | $0.0503 | $7.3401 | +22.38% |
| August, 2029 | $0.4802 | $0.2501 | $3.7601 | -83.21% |
| September, 2029 | $1.2204 | $0.8103 | $1.1404 | -57.33% |
| October, 2029 | $1.2507 | $1.2305 | $1.2107 | -56.27% |
| November, 2029 | $1.271 | $1.2808 | $1.1909 | -55.56% |
| December, 2029 | $1.1912 | $1.1311 | $1.1312 | -58.35% |
Sunshine Biopharma Inc Stock (SBFM) Price Forecast for 2030
Sunshine Biopharma Inc Stock (SBFM) is expected to reach an average price of $1.1722 in 2030, with a high forecast of $1.4016 and a low forecast of $0.9429. This signifies an -59.01% decrease from the last price of $2.86.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.4565 | $1.2514 | $1.3015 | -49.07% |
| February, 2030 | $1.1518 | $1.4818 | $1.4016 | -59.73% |
| March, 2030 | $1.4253 | $1.3619 | $1.3523 | -50.16% |
| April, 2030 | $1.3526 | $1.372 | $1.3423 | -52.71% |
| May, 2030 | $1.3725 | $1.4323 | $1.3935 | -52.01% |
| June, 2030 | $0.8228 | $1.0128 | $1.2326 | -71.23% |
| July, 2030 | $1.102 | $0.9429 | $1.0531 | -61.47% |
| August, 2030 | $1.1834 | $1.1281 | $1.0934 | -58.62% |
| September, 2030 | $1.2536 | $1.2634 | $1.2336 | -56.17% |
| October, 2030 | $1.285 | $1.2935 | $1.2585 | -55.07% |
| November, 2030 | $1.2982 | $1.2638 | $1.2552 | -54.61% |
| December, 2030 | $1.3141 | $1.3239 | $1.2984 | -54.05% |
1.11%
0.61%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):